Page last updated: 2024-11-12
lepadiformine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
lepadiformine: isolated from Clavelina lepadiformis (Muller) and C. molluccensis (Sluiter); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 10266421 |
| CHEMBL ID | 1186874 |
| MeSH ID | M0394372 |
Synonyms (5)
| Synonym |
|---|
| (-)-lepadiformine |
| lepadiformine |
| 155944-27-7 |
| CHEMBL1186874 |
| [(3s,5r,7as,11as)-5-hexyl-2,3,5,6,7,7a,8,9,10,11-decahydro-1h-pyrrolo[2,1-j]quinolin-3-yl]methanol |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (31)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (48.39) | 29.6817 |
| 2010's | 14 (45.16) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 22.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.60) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (6.45%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 29 (93.55%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||